ArticleBMJ open2026

Semaglutide as adjunct treatment for obesity in adolescents receiving antipsychotic medication (the GOAL trial): protocol for a single-arm, open-label feasibility study.

Laura Victoria Giraldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.